News

Innovative Partnership Enhances Wound Care Solutions at PAM Health

Innovative Partnership Enhances Wound Care Solutions at PAM Health

Nuo Therapeutics Collaborates with PAM Health for Enhanced Wound Care

Wound care patients at PAM Health facilities are set to benefit from a significant advancement in chronic wound healing through a groundbreaking partnership with Nuo Therapeutics, Inc. (OTCQB: AURX). This alliance marks a new chapter in the treatment of chronic wounds, as the Aurix System will become the exclusive platelet-rich plasma (PRP) therapy used across PAM Health's healthcare network, which includes long-term acute care hospitals, rehab facilities, and outpatient clinics.

Chronic Wounds: A Hidden Crisis

Chronic wounds represent a critical health issue in the U.S., affecting roughly 8 million individuals, particularly seniors who rely on Medicare. The financial implications are staggering, with estimates of Medicare expenditures on wound care ranging from $28.1 billion to $96.8 billion annually. Beyond the economic burden, the emotional and physical toll on patients is substantial, highlighting the urgent need for effective wound care therapies.

The Role of Aurix System in Effective Healing

The Aurix System stands out as the first FDA-cleared PRP therapy specifically designed for chronic wound management. By utilizing a quick one-minute spin process, the system creates a biologically active gel from the patient's own platelets and plasma. This innovative approach harnesses the body’s natural healing mechanisms, significantly improving healing times compared to traditional methods.

Nuo’s Vice President of Sales, Dave Hazard, emphasizes the importance of this collaboration, stating that it transcends mere product distribution. PAM Health's expansive clinical footprint across multiple states amplifies access to cutting-edge treatment, aiming to minimize complications and enhance healing outcomes for patients.

PAM Health's Commitment to Patient-Driven Care

At PAM Health, the focus is on delivering exceptional care through evidence-based strategies. SVP and Chief Business Officer Nick Fazzolari notes that integrating the Aurix System into their advanced wound care offerings is a testament to their dedication to patient-centered solutions. The goal is not just to treat wounds but to optimize overall patient wellness through innovative approaches.

PAM Health boasts over 100 healthcare facilities across 23 states, demonstrating its commitment to improving patient care through the integration of advanced technologies like the Aurix PRP therapy. This strategic initiative is aimed at addressing the needs of patients facing complex, chronic conditions, especially those who may be at risk of limb loss.

About Nuo Therapeutics

Nuo Therapeutics, Inc. is a pioneering company in the field of biodynamic therapies. Their flagship product, the Aurix System, is a notable FDA-cleared solution designed for chronic wound management, highlighting their commitment to harnessing the body's healing capabilities.

About PAM Health

PAM Health is dedicated to providing exceptional healthcare services through its expansive network of post-acute care facilities. Their commitment to quality patient care is underpinned by a highly skilled and compassionate workforce, ensuring that patients receive the best possible outcomes throughout their healing journey.

Frequently Asked Questions

What is the primary focus of the Nuo and PAM Health partnership?

The partnership is focused on delivering advanced regenerative wound healing therapies, specifically through the use of the Aurix System, across PAM Health facilities.

Why are chronic wounds a significant healthcare concern?

Chronic wounds affect a large portion of the population, leading to exorbitant healthcare costs and serious health complications if left untreated, particularly among elderly individuals.

What is the Aurix System?

The Aurix System is an FDA-cleared PRP therapy that utilizes a patient's own biological materials to accelerate wound healing, significantly enhancing recovery times.

How does PAM Health ensure high-quality patient care?

PAM Health prioritizes clinical excellence through evidence-based therapies and a dedicated staff committed to innovative and patient-centered care approaches.

What is the significance of the Aurix System for PAM Health?

Integrating the Aurix System into PAM Health’s wound care services reflects their strategic vision to provide comprehensive, effective, and innovative care solutions for chronic conditions.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Lee Enterprises Achieves Major Growth With $16.85 Stock Peak

Updated Category News Views 130

Lee Enterprises Stock Reaches New Heights Lee Enterprises, Incorporated (LEE) has recently made headlines as its stock hit a remarkable 52-week high, trading at $16.85. This surge is indicative of a 61.48% increase over the past year, capturing the attention of both investors and market analysts. Many are watching closely as the company continues to outperform...

Continue Reading
Exciting Upcoming Events by TurfMutt Foundation for Pet Lovers

Updated Category News Views 164

TurfMutt Foundation's Signature Events Announced for 2025 The TurfMutt Foundation is set to bring joy and bring together pet lovers and their furry friends at the upcoming Equip Exposition in 2025. This renowned foundation, known for its commitment to promoting green spaces and animal rescue, is excited to announce its signature events that promise to engage and inspire....

Continue Reading
Significant Advances in PNH Treatment with Novartis' Fabhalta

Updated Category News Views 171

Revolutionizing PNH Treatment with Fabhalta Novartis has showcased exciting developments in the realm of paroxysmal nocturnal hemoglobinuria (PNH) treatment through its innovative oral medication, Fabhalta. The recent Phase IIIB APPULSE-PNH study revealed that adults with PNH, who transitioned to Fabhalta, experienced a notable uptick in hemoglobin (Hb) levels, averaging...

Continue Reading
Current Net Asset Value Overview for Hargreave Hale AIM VCT

Updated Category News Views 146

Understanding the Latest NAV Announcement As of November 28, 2025, Hargreave Hale AIM VCT PLC has reported its unaudited Net Asset Value (NAV). This financial metric is crucial for investors, as it gives a clear indication of the company's performance and value. The NAV per ordinary share of 1p stands at an impressive 35.27 pence, speaking volumes about the company’s...

Continue Reading
Timbercreek Financial Announces Monthly Dividend for Shareholders

Updated Category News Views 243

Timbercreek Financial Announces Exciting Dividend Update Timbercreek Financial (TSX: TF) has made a positive announcement regarding its dividends. Recently, the Company declared a monthly cash dividend of $0.0575 for every common share, showing their commitment to returning value to their shareholders. Dividend Payment Details This dividend is set to be paid on a...

Continue Reading